Anticoagulation Control in Different Ethnic Groups Receiving Vitamin K Antagonist for Stroke Prevention in Atrial Fibrillation

Vitamin K antagonist such as warfarin reduces the risk of stroke in atrial fibrillation (AF) patients. Since warfarin has a narrow therapeutic index, its administration needs to be regularly monitored to avoid any adverse clinical outcomes such as stroke and bleeding. The quality of anticoagulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Zawawi, Nur Azyyati, Abdul Halim Zaki, Izzati, Ming, Long Chiau, Goh, Hui Poh, Zulkifly, Hanis Hanum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635010/
https://www.ncbi.nlm.nih.gov/pubmed/34869639
http://dx.doi.org/10.3389/fcvm.2021.736143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635010/
https://www.ncbi.nlm.nih.gov/pubmed/34869639
http://dx.doi.org/10.3389/fcvm.2021.736143

Ejemplares similares